Emerging Molecularly Defined Bone and Soft Tissue Diagnoses: When Do They Matter?

Area of Science:

• Oncology
• Molecular Pathology
• Genomics

Background:

• Advances in molecular pathology and genomic data are refining neoplasm classification.
• Three specific mesenchymal neoplasms have been recently reclassified based on molecular genetics.
• Accurate diagnosis of these tumors is critical due to differing prognoses and management of mimickers.

Purpose of the Study:

• To introduce and discuss three recently classified mesenchymal neoplasms.
• To highlight key clinicopathologic features for accurate diagnosis.
• To provide strategies for differential diagnosis and avoid pitfalls.

Main Methods:

• Review of recent classifications of mesenchymal neoplasms.
• Discussion of clinicopathologic features.
• Outline of ancillary studies and molecular characterization.

Main Results:

• Introduction of SRF-rearranged myoid neoplasm (formerly cellular myofibroma).
• Description of superficial CD34-positive fibroblastic tumor.
• Overview of kinase-altered spindle cell neoplasms.

Conclusions:

• Accurate diagnosis of these neoplasms is essential for appropriate patient management.
• Molecular characterization plays a key role in definitive diagnosis.
• Understanding these entities aids in avoiding diagnostic pitfalls and improving patient outcomes.